Domain experts in technologies and heart, lung, blood, and sleep disorders are charged with opening and maintaining a dialogue between B-BIC and the clinicians and researchers at the front line of care and research. Domain experts work with B-BIC to assess areas of clinical unmet need, seek out and connect with clinicians and scientists who have creative ideas about applying technologies to patient-care solutions, provide seasoned guidance and mentorship of young investigators, and provide expert reviews of proposals submitted to B-BIC in its efforts to identify projects chosen for development.
Nancy Berliner, M.D. - Brigham and Women's Hospital
Chief, Division of Hematology and Professor of Medicine, Harvard Medical School. Her research spans the fields of both benign and malignant hematologic disorders. She is Deputy Editor for Blood, and a member of the Institute of Medicine.
John Brownstein, Ph.D. - Boston Children's Hospital
Dr. Brownstein is an Associate Professor at the Harvard Medical School and a faculty member of the Children's Hospital Informatics Program at Harvard-MIT Division of Health Sciences and Technology. Dr. Brownstein works on new statistical modeling and medical informatics approaches for accelerating the translation of public health surveillance research into practice.
FAROUC JAFFER, M.D., PH.D - MASSACHUSETTS GENERAL HOSPITAL
Farouc Jaffer is an Associate Professor of Medicine at Harvard Medical School. In 2013, he was elected to the American Society of Clinical Investigation (ASCI). He is the Director of Vascular Imaging at the Cardiovascular Molecular Imaging Program. His lab is interested in applying molecular imaging technology to 1) understand the evolution and therapy of inflammation in atherosclerosis though serial, high-resolution imaging and 2) develop translatable, catheter-based fluorescence technology to study vascular disease in human coronary sized arteries.
Ellis J. Neufeld, M.D, Ph.D. - Boston Children's Hospital
Dr. Neufeld received both MD and PhD degrees in 1985 from Washington University, St. Louis. He completed specialty training in Pediatrics and Medical Genetics at Boston Children’s Hospital, and in Pediatric Hematology/Oncology at Dana-Farber Cancer Institute and Boston Children’s, where he joined the faculty in 1990. Dr. Neufeld is co-chief of the Clinical Research Center and Program Director of the Clinical and Translational Studies Unit at Boston Children’s. He is an international leader in studies of pediatric ITP, treatment of iron overload in transfused patients with thalassemia and related disorders, as well as studies of the genes that cause inherited blood disorders.
Stuart Orkin, M.D. - Boston Children’s Hospital
Chairman of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute. Over the last 20 years his laboratory has focused on the molecular biology and genetics of blood and stem cell development and other hematologic disorders with a recent emphasis on the biology of hematologic stem cells.
Susan Redline, M.D. - Brigham and Women's Hospital
Dr. Redline is the Peter C. Farrell Professor of Medicine, Harvard Medical School. She directs the Program in Sleep and Cardiovascular Medicine based at Harvard Medical School that has as a key aim the identification and evaluation of interventions to improve sleep health and reduce related cardiovascular and metabolic morbidities. She leads the National Sleep Reseach Resource, a NHLBI resource for disseminating sleep and other data to the scientific community, and also the Sleep Apnea Patient Centered Outcomes Network, which is a patient powered research network within PCORI's PCORnet.
David Scadden, M.D. - Massachusetts General Hospital
He is the Gerald and Darlene Jordan Professor of Medicine, Harvard Medical School, Co-Director, and co-founder, Harvard Stem Cell Institute. His laboratory focuses on the regulation of hematopoiesis by both hematopoietic cell autonomous and non-autonomous means, with particular emphasis on the hematopoietic stem cell niche and its role in normal and malignant disease.
Frederick J. Schoen, M.D. Ph.D - Brigham and Women's Hospital
Dr. Schoen is Senior Pathologist at Brigham and Women's Hospital, Professor of Pathology and Health Sciences and Technology, Harvard Medical School and Executive Vice Chairman, Department of Pathology, Brigham and Women's Hospital. Dr. Schoen investigates medical device development and pathology, mechanical and tissue heart valve substitutes and tissue engineering of heart valves.
Gary Tearney, M.D., Ph.D. - Massachusetts General Hospital
Professor of Pathology, Harvard Medical School, and Associate Director, Wellman Center for Photomedicine. He has spent over 20 years developing and validating new imaging technologies to combat human disease, most notably optical coherence tomography (OCT) technology. He directs a laboratory responsible for first-in-human studies with pulmonary, coronary vessel, and esophageal OCT devices and he is currently the PI of approximately 10 clinical trials that investigate the clinical utility of these technologies.
Scott Weiss, M.D. - Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School, Director of the Partners Health Care Center for Personalized Genetic Medicine (PCPGM), Associate Director of the Channing Division of Network Medicine and the co-leader of the Systems Genetics and Genomics research group at the Channing Division of Network Medicine, Department of Medicine, BWH. Dr. Weiss has authored or co-authored over 550 papers and co-written and co-edited four books, including a comprehensive textbook in respiratory genetics. He has been continuously funded by NHLBI for 38 years and was recently identified as part of the top 1% of biomedical researchers in terms of impact (Eur J Clin Investigation 2013 PMID: 24134636).